{"schema_version":"secwatch.filing_event.v1","accession":"0001159036-26-000126","form_type":"8-K","ticker":"HALO","cik":"0001159036","company_name":"HALOZYME THERAPEUTICS, INC.","filed_at":"2026-09-18T12:23:28+00:00","discovered_at":"2026-09-18T12:25:01.415540+00:00","generated_at":"2026-09-18T12:25:10.039061+00:00","sec_items":["8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Halozyme prices $1.3B convertible senior notes due 2033 at 1.50%; upsized from $1.05B","bullets":["$1.3B aggregate principal of 1.50% convertible notes due Oct 1, 2033, upsized from $1.05B; 13-day greenshoe for up to $200M.","Initial conversion price ~$139.84/share (27.5% premium above $109.68 close); cap price of capped calls ~$208.39/share.","Net proceeds ~$1.275B; ~$162.5M funds capped calls, remainder for note repurchases, working capital, acquisitions.","To repurchase ~$151.7M of 0.25% 2027 notes (cost ~$217.0M) and $220.0M of 1.00% 2028 notes (cost ~$435.5M).","Closing expected Sept 22, 2026; offering private to QIBs under Rule 144A; settle conversions in cash plus shares if applicable."],"urls":{"canonical":"https://secwatch.observer/filing/0001159036-26-000126","json":"https://secwatch.observer/filing/0001159036-26-000126.json","markdown":"https://secwatch.observer/filing/0001159036-26-000126.md","text":"https://secwatch.observer/filing/0001159036-26-000126.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000126/0001159036-26-000126-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000126/halo-20260917.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-18T12:25:10.039061+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}